Challenges And Opportunities For MSC Expansion Workflows

Scaling mesenchymal stem cell expansion presents complex engineering challenges, from surface area constraints to escalating media costs. Transitioning from small-scale T-flasks to high-density multi-layer vessels or automated bioreactor systems dramatically alters yield efficiency and footprint requirements. Evaluating parameters like surface growth area, culture media consumption, and incubation capacity is essential for optimizing cost-per-batch without compromising therapeutic quality. Standardizing closed-system operations further minimizes contamination risk and protects process integrity during commercial scale-up. Furthermore, upstream expansion strategies must align with downstream processing capabilities, ensuring centrifugation and harvest workflows seamlessly manage increased harvest volumes. Understanding these key trade-offs enables developers to streamline clinical translation, reduce manufacturing overhead, and expand patient access to advanced cell therapies. Explore the full presentation to discover detailed technical evaluations and practical scale-up insights.